A detailed history of Verition Fund Management LLC transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 17,290 shares of IDYA stock, worth $555,700. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,290
Previous 60,887 71.6%
Holding current value
$555,700
Previous $1.28 Million 63.25%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$21.12 - $27.21 $920,768 - $1.19 Million
-43,597 Reduced 71.6%
17,290 $470,000
Q2 2025

Aug 14, 2025

SELL
$14.5 - $22.63 $377,087 - $588,515
-26,006 Reduced 29.93%
60,887 $1.28 Million
Q1 2025

May 15, 2025

BUY
$16.38 - $26.0 $504,258 - $800,410
30,785 Added 54.87%
86,893 $1.42 Million
Q4 2024

Feb 14, 2025

BUY
$24.79 - $31.98 $1.2 Million - $1.55 Million
48,337 Added 622.02%
56,108 $1.44 Million
Q3 2024

Nov 14, 2024

BUY
$30.37 - $43.05 $236,005 - $334,541
7,771 New
7,771 $246,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.54B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.